Identification of a new phenotype of tolerogenic human dendritic cells induced by fungal proteases from Aspergillus oryzae

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 3966-3976

  Zimmer, Aline ^a   Luce, Sonia ^a   Gaignier, Fanny ^a   Nony, Emmanuel ^a   Naveau, Marie ^a   Biola Vidamment, Armelle ^b   Pallardy, Marc ^b   Van Overtvelt, Laurence ^a   Mascarell, Laurent ^a   Moingeon, Philippe ^a  

^a Faculté de Pharmacie ^*  (France)

^b Universite Paris Sud   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CCL1 CHEMOKINE; CYSTEINE; DEXAMETHASONE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOCORTICOID INDUCED LEUCINE ZIPPER PROTEIN; GLUCOCORTICOID RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LEUCINE ZIPPER PROTEIN; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; METALLOPROTEINASE; PROTEINASE; RETINAL DEHYDROGENASE; RETINALDEHYDE DEHYDROGENASE 1; RETINALDEHYDE DEHYDROGENASE 2; SECONDARY LYMPHOID TISSUE CHEMOKINE; SERINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLUS ORYZAE; CD4+ T LYMPHOCYTE; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATOR GENE; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TOLEROGENIC DENDRITIC CELL;

EID: 79955030896     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003184     Document Type: Article

References (76)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252. (Pubitemid 28155090)
2. van Beelen, A. J., Z. Zelinkova, E. W. Taanman-Kueter, F. J. Muller, D. W. Hommes, S. A. Zaat, M. L. Kapsenberg, and E. C. de Jong. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27: 660-669. (Pubitemid 47615504)
3. de Jong, E. C., P. L. Vieira, P. Kalinski, J. H. Schuitemaker, Y. Tanaka, E. A. Wierenga, M. Yazdanbakhsh, and M. L. Kapsenberg. 2002. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J. Immunol. 168: 1704-1709. (Pubitemid 34135767)
4. Gregori, S., D. Tomasoni, V. Pacciani, M. Scirpoli, M. Battaglia, C. F. Magnani, E. Hauben, and M. G. Roncarolo. 2010. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116: 935-944.
5. Ilarregui, J. M., D. O. Croci, G. A. Bianco, M. A. Toscano, M. Salatino, M. E. Vermeulen, J. R. Geffner, and G. A. Rabinovich. 2009. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 10: 981-991.
6. Adorini, L., N. Giarratana, and G. Penna. 2004. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin. Immunol. 16: 127-134. (Pubitemid 38234763)
7. Pulendran, B., H. Tang, and S. Manicassamy. 2010. Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat. Immunol. 11: 647-655.
8. Boissier, M. C., E. Assier, J. Biton, A. Denys, G. Falgarone, and N. Bessis. 2009. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 76: 10-14.
9. Trenado, A., S. Fisson, E. Braunberger, D. Klatzmann, B. L. Salomon, and J. L. Cohen. 2004. Ex vivo selection of recipient-type alloantigen-specific CD4 (+)CD25(+) immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation. Transplantation 77 (1 Suppl): S32-S34. (Pubitemid 38114417)
10. Turnquist, H. R., R. T. Fischer, and A. W. Thomson. 2010. Pharmacological modification of dendritic cells to promote their tolerogenicity in transplantation. Methods Mol. Biol. 595: 135-148.
11. +CD25+CD127- T regulatory cells. Clin. Immunol. 133: 22-26.
12. Palomares, O., G. Yaman, A. K. Azkur, T. Akkoc, M. Akdis, and C. A. Akdis. 2010. Role of Treg in immune regulation of allergic diseases. Eur. J. Immunol. 40: 1232-1240.
13. Bohle, B., T. Kinaciyan, M. Gerstmayr, A. Radakovics, B. Jahn-Schmid, and C. Ebner. 2007. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J. Allergy Clin. Immunol. 120: 707-713. (Pubitemid 47320765)
14. Rescigno, M. 2010. Dendritic cells in tolerance induction for the treatment of autoimmune diseases. Eur. J. Immunol. 40: 2119-2123.
15. Bosma, B. M., H. J. Metselaar, N. M. Nagtzaam, R. de Haan, S. Mancham, L. J. van der Laan, E. J. Kuipers, and J. Kwekkeboom. 2008. Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells. Immunology 125: 91-100.
16. Unger, W. W., S. Laban, F. S. Kleijwegt, A. R. van der Slik, and B. O. Roep. 2009. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD-L1. Eur. J. Immunol. 39: 3147-3159.
17. Pedersen, A. W., K. Holmstrøm, S. S. Jensen, D. Fuchs, S. Rasmussen, P. Kvistborg, M. H. Claesson, and M. B. Zocca. 2009. Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin. Exp. Immunol. 157: 48-59.
18. Woltman, A. M., J. W. de Fijter, S. W. Kamerling, L. C. Paul, M. R. Daha, and C. van Kooten. 2000. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur. J. Immunol. 30: 1807-1812. (Pubitemid 30456176)
19. Xia, C. Q., R. Peng, F. Beato, and M. J. Clare-Salzler. 2005. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol. 62: 45-54. (Pubitemid 41025877)
20. Emmer, P. M., J. van der Vlag, G. J. Adema, and L. B. Hilbrands. 2006. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation 81: 1451-1459. (Pubitemid 43852991)
21. Vizzardelli, C., N. Pavelka, A. Luchini, I. Zanoni, L. Bendickson, M. Pelizzola, O. Beretta, M. Foti, F. Granucci, M. Nilsen-Hamilton, and P. Ricciardi-Castagnoli. 2006. Effects of dexamethazone on LPS-induced activationand migration of mouse dendritic cells revealed by a genome-wide transcriptional analysis. Eur. J. Immunol. 36: 1504-1515. (Pubitemid 43942139)
22. Roelen, D. L., D. H. Schuurhuis, D. E. van den Boogaardt, K. Koekkoek, P. P. van Miert, J. J. van Schip, S. Laban, D. Rea, C. J. Melief, R. Offringa, et al. 2003. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 76: 1608-1615. (Pubitemid 37549835)
23. Manavalan, J. S., P. C. Rossi, G. Vlad, F. Piazza, A. Yarilina, R. Cortesini, D. Mancini, and N. Suciu-Foca. 2003. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11: 245-258. (Pubitemid 37120544)
24. Chang, C. C., R. Ciubotariu, J. S. Manavalan, J. Yuan, A. I. Colovai, F. Piazza, S. Lederman, M. Colonna, R. Cortesini, R. Dalla-Favera, and N. Suciu-Foca. 2002. Tolerization of dendritic cells by T(S) cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3: 237-243. (Pubitemid 34218114)
25. Svajger, U., A. Vidmar, and M. Jeras. 2008. Niflumic acid renders dendritic cellstolerogenic and up-regulates inhibitory molecules ILT3 and ILT4. Int. Immunopharmacol.8: 997-1005.
26. Gleissner, C. A., and T. J. Dengler. 2009. Induction of ILT expression on nonprofessional antigen presenting cells: Clinical applications. Hum. Immunol. 70: 357-359.
27. Vlad, G., C. C. Chang, A. I. Colovai, E. R. Vasilescu, R. Cortesini, and N. Suciu- Foca. 2010. Membrane and soluble ILT3 are critical to the generation of T suppressor cells and induction of immunological tolerance. Int. Rev. Immunol. 29: 119-132.
28. +CD25+ Foxp3+ T regulatory cells. J. Immunol. 183: 145-154.
29. Cohen, N., E. Mouly, H. Hamdi, M. C. Maillot, M. Pallardy, V. Godot, F. Capel, A. Balian, S. Naveau, P. Galanaud, et al. 2006. GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 107: 2037-2044. (Pubitemid 43289388)
30. Hamdi, H., V. Godot, M. C. Maillot, M. V. Prejean, N. Cohen, R. Krzysiek, F. M. Lemoine, W. Zou, and D. Emilie. 2007. Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood 110: 211-219. (Pubitemid 47026837)
31. Ayroldi, E., G. Migliorati, S. Bruscoli, C. Marchetti, O. Zollo, L. Cannarile, F. D'Adamio, and C. Riccardi. 2001. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 98: 743-753.
32. Sun, C. M., J. A. Hall, R. B. Blank, N. Bouladoux, M. Oukka, J. R. Mora, and Y. Belkaid. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204: 1775-1785. (Pubitemid 47236316)
33. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Cárcamo, J. Hall, C. M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764. (Pubitemid 47236314)
34. Geissmann, F., P. Revy, N. Brousse, Y. Lepelletier, C. Folli, A. Durandy, P. Chambon, and M. Dy. 2003. Retinoids regulate survival and antigen presentation by immature dendritic cells. J. Exp. Med. 198: 623-634. (Pubitemid 37040396)
35. Manicassamy, S., and B. Pulendran. 2009. Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages. Semin. Immunol. 21: 22-27.
36. Guilliams, M., K. Crozat, S. Henri, S. Tamoutounour, P. Grenot, E. Devilard, B. de Bovis, L. Alexopoulou, M. Dalod, and B. Malissen. 2010. Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells. Blood 115: 1958- 1968.
37. Chen, C., W. H. Lee, L. Zhong, and C. P. Liu. 2006. Regulatory T cells can mediate their function through the stimulation of APCs to produce immunosuppressive nitric oxide. J. Immunol. 176: 3449-3460. (Pubitemid 43363992)
38. Ogawa, A., A. Yasuhara, T. Tanaka, T. Sakiyama, and K. Nakanishi. 1995. Production of neutral protease by membrane-surface liquid culture of Aspergillus oryzae IAM2704. J. Ferment. Bioeng. 80: 35-40.
39. Manome, H., S. Aiba, and H. Tagami. 1999. Simple chemicals can induce maturation and apoptosis of dendritic cells. Immunology 98: 481-490. (Pubitemid 30005327)
40. Ohtani, T., M. Mizuashi, S. Nakagawa, Y. Sasaki, T. Fujimura, R. Okuyama, and S. Aiba. 2009. TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation. Immunology 126: 485-499.
41. Asselin-Labat, M. L., M. David, A. Biola-Vidamment, D. Lecoeuche, M. C. Zennaro, J. Bertoglio, and M. Pallardy. 2004. GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis. Blood 104: 215-223. (Pubitemid 38879860)
42. Kushwah, R., J. Wu, J. R. Oliver, G. Jiang, J. Zhang, K. A. Siminovitch, and J. Hu. 2010. Uptake of apoptotic DC converts immature DC into tolerogenic DC, which induce differentiation of Foxp3+ regulatory T cells. Eur. J. Immunol. 40: 1022-1035.
43. Kushwah, R., and J. Hu. 2010. Dendritic cell apoptosis: Regulation of tolerance versus immunity. J. Immunol. 185: 795-802.
44. Belladonna, M. L., C. Volpi, R. Bianchi, C. Vacca, C. Orabona, M. T. Pallotta, L. Boon, S. Gizzi, M. C. Fioretti, U. Grohmann, and P. Puccetti. 2008. Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. J. Immunol. 181: 5194-5198.
45. Steinbrink, K., E. Graulich, S. Kubsch, J. Knop, and A. H. Enk. 2002. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99: 2468-2476. (Pubitemid 34525434)
46. Delgado, M. 2009. Generating tolerogenic dendritic cells with neuropeptides. Hum. Immunol. 70: 300-307.
47. Pozo, D., P. Anderson, and E. Gonzalez-Rey. 2009. Induction of alloantigenspecific human T regulatory cells by vasoactive intestinal peptide. J. Immunol. 183: 4346-4359.
48. Jiga, L. P., T. M. Bauer, J. J. Chuang, G. Opelz, and P. Terness. 2004. Generation of tolerogenic dendritic cells by treatment with mitomycin C: Inhibition of allogeneic T-cell response is mediated by downregulation of ICAM-1, CD80, and CD86. Transplantation 77: 1761-1764. (Pubitemid 38780546)
49. Haidinger, M., M. Poglitsch, R. Geyeregger, S. Kasturi, M. Zeyda, G. J. Zlabinger, B. Pulendran, W. H. Hörl, M. D. Säemann, and T. Weichhart. 2010. A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation. J. Immunol. 185: 3919-3931.
50. Széles, L., G. Keresztes, D. Töröcsik, Z. Balajthy, L. Krenács, S. Póliska, A. Steinmeyer, U. Zuegel, M. Pruenster, A. Rot, and L. Nagy. 2009. 1,25- dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J. Immunol. 182: 2074-2083.
51. Manicassamy, S., R. Ravindran, J. Deng, H. Oluoch, T. L. Denning, S. P. Kasturi, K. M. Rosenthal, B. D. Evavold, and B. Pulendran. 2009. Toll-like receptor 2- dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat. Med. 15: 401-409.
52. Henry, E., C. J. Desmet, V. Garzé, L. Fiévez, D. Bedoret, C. Heirman, P. Faisca, F. J. Jaspar, P. Gosset, A. P. Jacquet, et al. 2008. Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J. Immunol. 181: 7230-7242.
53. Gorczynski, R. M., J. Bransom, M. Cattral, X. Huang, J. Lei, L. Xiaorong, W. P. Min, Y. Wan, and J. Gauldie. 2000. Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFbeta and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2. Clin. Immunol. 95: 182-189. (Pubitemid 30346677)
54. Wang, Q., Y. Liu, J.Wang, G. Ding,W. Zhang, G. Chen, M. Zhang, S. Zheng, and X. Cao. 2006. Induction of allospecific tolerance by immature dendritic cells genetically modified to express soluble TNF receptor. J. Immunol. 177: 2175-2185. (Pubitemid 44200976)
55. Tan, P. H., J. B. Yates, S. A. Xue, C. Chan, W. J. Jordan, J. E. Harper, M. P. Watson, R. Dong, M. A. Ritter, R. I. Lechler, et al. 2005. Creation of tolerogenic human dendritic cells via intracellular CTLA4: A novel strategy with potential in clinical immunosuppression. Blood 106: 2936-2943. (Pubitemid 41565883)
56. Lipscomb, M. W., J. L. Taylor, C. J. Goldbach, S. C. Watkins, A. K. Wesa, and W. J. Storkus. 2010. DC expressing transgene Foxp3 are regulatory APC. Eur. J. Immunol. 40: 480-493.
57. + T-regulatory cells. Transplantation 79: 1056-1061. (Pubitemid 40663997)
58. Orabona, C., P. Puccetti, C.Vacca, S. Bicciato, A. Luchini, F. Fallarino, R. Bianchi, E. Velardi, K. Perruccio, A. Velardi, et al. 2006. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 107: 2846-2854.
59. Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774. (Pubitemid 39336293)
60. Munn, D. H., M. D. Sharma, J. R. Lee, K. G. Jhaver, T. S. Johnson, D. B. Keskin, B. Marshall, P. Chandler, S. J. Antonia, R. Burgess, et al. 2002. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297: 1867-1870. (Pubitemid 35024345)
61. Yanagawa, Y., K. Iwabuchi, and K. Onoé. 2009. Co-operative action of interleukin-10 and interferon-gamma to regulate dendritic cell functions. Immunology 127: 345-353.
62. Hill, M., R. Zagani, C. Voisine, C. Usal, and I. Anegon. 2007. Nitric oxide and indoleamine 2,3-dioxygenase mediate CTLA4Ig-induced survival in heart allografts in rats. Transplantation 84: 1060-1063. (Pubitemid 350287389)
63. Xiao, S., H. Jin, T. Korn, S. M. Liu, M. Oukka, B. Lim, and V. K. Kuchroo. 2008. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181: 2277-2284.
64. Kang, S. G., H. W. Lim, O. M. Andrisani, H. E. Broxmeyer, and C. H. Kim. 2007. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol. 179: 3724-3733.
65. Montagnoli, C., F. Fallarino, R. Gaziano, S. Bozza, S. Bellocchio, T. Zelante, W. P. Kurup, L. Pitzurra, P. Puccetti, and L. Romani. 2006. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol. 176: 1712-1723. (Pubitemid 43134316)
66. Bozza, S., C. Clavaud, G. Giovannini, T. Fontaine, A. Beauvais, J. Sarfati, C. D'Angelo, K. Perruccio, P. Bonifazi, S. Zagarella, et al. 2009. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J. Immunol. 183: 2407-2414.
67. Fukahori, S., H. Matsuse, T. Tsuchida, T. Kawano, S. Tomari, C. Fukushima, and S. Kohno. 2010. Aspergillus fumigatus regulates mite allergen-pulsed dendritic cells in the development of asthma. Clin. Exp. Allergy 40: 1507-1515.
68. Lamhamedi-Cherradi, S. E., R. E. Martin, T. Ito, F. Kheradmand, D. B. Corry, Y. J. Liu, and M. Moyle. 2008. Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12. J. Immunol. 180: 6000-6009.
69. Kheradmand, F., A. Kiss, J. Xu, S. H. Lee, P. E. Kolattukudy, and D. B. Corry. 2002. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 169: 5904-5911. (Pubitemid 35291696)
70. Phillips, C., W. R. Coward, D. I. Pritchard, and C. R. Hewitt. 2003. Basophils express a type 2 cytokine profile on exposure to proteases from helminths and house dust mites. J. Leukoc. Biol. 73: 165-171. (Pubitemid 36125687)
71. Sokol, C. L., G. M. Barton, A. G. Farr, and R. Medzhitov. 2008. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat. Immunol. 9: 310-318. (Pubitemid 351267328)
72. Kouzaki, H., S. M. O'Grady, C. B. Lawrence, and H. Kita. 2009. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J. Immunol. 183: 1427-1434.
73. Maynard, C. L., R. D. Hatton, W. S. Helms, J. R. Oliver, C. B. Stephensen, and C. T. Weaver. 2009. Contrasting roles for all-trans retinoic acid in TGF-betamediated induction of Foxp3 and Il10 genes in developing regulatory T cells. J. Exp. Med. 206: 343-357.
74. Ristich, V., W. Zhang, S. Liang, and A. Horuzsko. 2007. Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells. Hum. Immunol. 68: 264-271. (Pubitemid 46497523)
75. Ristich, V., S. Liang, W. Zhang, J. Wu, and A. Horuzsko. 2005. Tolerization of dendritic cells by HLA-G. Eur. J. Immunol. 35: 1133-1142. (Pubitemid 40542220)
76. Adorini, L., and G. Penna. 2009. Dendritic cell tolerogenicity: A key mechanism in immunomodulation by vitamin D receptor agonists. Hum. Immunol. 70: 345-352.